Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 79589L106 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
| Price T Rowe Associates Inc /MD/ 13G/A Amendment 1 | 13.1% |
8/14/2026
Event 6/30/2026
|
|
| Price T Rowe Associates Inc /MD/ 13G | 10.0% |
5/15/2026
Event 3/31/2026
|
|
| Sanjit Biswas 13G/A Amendment 5 | 21.6% |
5/14/2026
Event 3/31/2026
|
|
|
Morgan Stanley
13G/A
Amendment 1
|
1.5% |
5/12/2026
Event 3/31/2026
|
|
| Morgan Stanley | 1.5% | ||
| Morgan Stanley Investment Management Inc. | 1.1% | ||
|
Sands Capital Management, LLC
13G/A
Amendment 3
|
4.4% |
5/8/2026
Event 3/31/2026
|
|
| Sands Capital Management, LLC | 4.2% | ||
| Sands Capital Alternatives, LLC | 0.1% | ||
| Sands Capital Scaling Innovation Fund, L.P. | 0% | ||
| Sands Frank M. | 4.4% | ||
| Baillie Gifford & Co 13G/A Amendment 7 | 15.6% |
5/7/2026
Event 3/31/2026
|
|
|
FMR LLC
13G
|
6.5% |
5/6/2026
Event 3/31/2026
|
|
| FMR LLC | 6.5% | ||
| Abigail P. Johnson | 6.5% | ||
| Vanguard Group Inc 13G/A Amendment 4 | 0% |
3/27/2026
Event 3/13/2026
|
|
| John Bicket 13G/A Amendment 5 | 21.3% |
2/12/2026
Event 12/31/2025
|
|
| Baillie Gifford & Co 13G/A Amendment 6 | 13.3% |
2/10/2026
Event 12/31/2025
|
|
| BlackRock, Inc. 13G | 5.6% |
1/21/2026
Event 12/31/2025
|
|
| Price T Rowe Associates Inc /MD/ 13G/A Amendment 3 | 4.9% |
11/14/2025
Event 9/30/2025
|
|
|
Sands Capital Management, LLC
13G/A
Amendment 2
|
6.1% |
11/13/2025
Event 9/30/2025
|
|
| Sands Capital Management, LLC | 5.9% | ||
| Sands Capital Alternatives, LLC | 0.2% | ||
| Sands Capital Scaling Innovation Fund, L.P. | 0% | ||
| Sands Frank M. | 6.1% | ||
| Baillie Gifford & Co 13G/A Amendment 5 | 11.9% |
11/12/2025
Event 9/30/2025
|
|
| BlackRock, Inc. 13G/A Amendment 1 | 4.9% |
10/17/2025
Event 9/30/2025
|
|
|
Andreessen Horowitz Fund IV, L.P.
13D/A
Amendment 10
|
1.2% |
9/10/2025
Event 9/8/2025
|
|
| Andreessen Horowitz Fund IV, L.P. | 0% | ||
| AH Equity Partners IV, L.L.C. | 0% | ||
| AH Parallel Fund IV, L.P. | 0% | ||
| AH Equity Partners IV (Parallel), L.L.C. | 0% | ||
| AH Parallel Fund V, L.P. | 0% | ||
| AH Equity Partners V (Parallel), L.L.C. | 0% | ||
| Andreessen Horowitz LSV Fund I, L.P. | 0% | ||
| AH Equity Partners LSV I, L.L.C. | 0% | ||
| Andreessen Horowitz LSV Fund III, L.P. | 0% | ||
| AH Equity Partners LSV III, L.L.C. | 0% | ||
| Marc L. Andreessen | 1.2% | ||
| Benjamin A. Horowitz | 1.2% | ||
| Baillie Gifford & Co 13G | 14.6% |
8/8/2025
Event 6/30/2025
|
|
|
Morgan Stanley
13G
|
5.1% |
8/6/2025
Event 6/30/2025
|
|
| Morgan Stanley | 5.1% | ||
| Morgan Stanley Investment Management Inc. | 5.0% | ||
|
FMR LLC
13G/A
Amendment 1
|
3.4% |
8/6/2025
Event 6/30/2025
|
|
| FMR LLC | 3.4% | ||
| Abigail P. Johnson | 3.4% | ||
| Vanguard Group Inc 13G/A Amendment 3 | 9.3% |
7/29/2025
Event 6/30/2025
|
|
| BlackRock, Inc. 13G | 5.5% |
7/17/2025
Event 6/30/2025
|
|
|
Sands Capital Management, LLC
13G/A
Amendment 1
|
6.6% |
7/8/2025
Event 6/30/2025
|
|
| Sands Capital Management, LLC | 6.4% | ||
| Sands Frank M. | 6.6% | ||
| Sands Capital Alternatives, LLC | 0.1% | ||
| Sands Capital Global Innovation Fund-Public Opportunities, L.P. | 0% | ||
|
General Catalyst Group Management Holdings GP, LLC
13D/A
Amendment 6
|
4.0% |
6/16/2025
Event 6/12/2025
|
|
| General Catalyst Group Management Holdings GP, LLC | 4.0% | ||
| General Catalyst Group Management Holdings, L.P. | 4.0% | ||
| General Catalyst Group Management, LLC | 4.0% | ||
| General Catalyst Group VIII, L.P. | 4.0% | ||
| General Catalyst Partners VIII, L.P. | 4.0% | ||
| General Catalyst GP VIII, LLC | 4.0% | ||
| General Catalyst Group X - Endurance, L.P. | 4.0% | ||
| General Catalyst Partners X - Growth Venture, L.P. | 4.0% | ||
| General Catalyst GP X - Growth Venture, LLC | 4.0% | ||
| General Catalyst Group XI - Endurance, L.P. | 4.0% | ||
| General Catalyst Partners XI - Endurance, L.P. | 4.0% | ||
| General Catalyst Endurance GP XI, LLC | 4.0% | ||
|
Andreessen Horowitz Fund IV, L.P.
13D/A
Amendment 9
|
5.7% |
6/11/2025
Event 6/9/2025
|
|
| Andreessen Horowitz Fund IV, L.P. | 3.2% | ||
| AH Equity Partners IV, L.L.C. | 3.2% | ||
| AH Parallel Fund IV, L.P. | 0.3% | ||
| AH Equity Partners IV (Parallel), L.L.C. | 0.3% | ||
| AH Parallel Fund V, L.P. | 0.8% | ||
| AH Equity Partners V (Parallel), L.L.C. | 0.8% | ||
| Andreessen Horowitz LSV Fund I, L.P. | 0.5% | ||
| AH Equity Partners LSV I, L.L.C. | 0.5% | ||
| Andreessen Horowitz LSV Fund III, L.P. | 0% | ||
| AH Equity Partners LSV III, L.L.C. | 0% | ||
| Marc L. Andreessen | 5.7% | ||
| Benjamin A. Horowitz | 5.7% | ||
|
Sands Capital Management, LLC
13G
|
5.6% |
5/14/2025
Event 3/31/2025
|
|
| Sands Capital Management, LLC | 5.6% | ||
| Sands Frank M. | 5.6% | ||
| Sanjit Biswas 13G/A Amendment 4 | 26.3% |
5/13/2025
Event 3/31/2025
|
|
| John Bicket 13G/A Amendment 4 | 25.6% |
5/13/2025
Event 3/31/2025
|
|
|
Morgan Stanley
13G/A
Amendment 6
|
3.6% |
5/7/2025
Event 3/31/2025
|
|
| Morgan Stanley | 3.6% | ||
| Morgan Stanley Investment Management Inc. | 3.6% | ||
| Price T Rowe Associates Inc /MD/ 13G/A Amendment 2 | 6.0% |
2/14/2025
Event 12/31/2024
|
|
| Baillie Gifford & Co 13G/A Amendment 3 | 12.2% |
2/12/2025
Event 12/31/2024
|
|
|
Morgan Stanley
13G/A
Amendment 5
|
7.6% |
2/4/2025
Event 12/31/2024
|
|
| Morgan Stanley | 7.6% | ||
| Morgan Stanley Investment Management Inc. | 7.6% | ||
| BlackRock, Inc. 13G/A Amendment 1 | 4.5% |
2/3/2025
Event 12/31/2024
|
|
| Baillie Gifford & Co 13G/A Amendment 2 | 15.1% |
11/7/2024
Event 9/30/2024
|
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 22 | 1.82 M | $69.2 M |
| 2026 Q2 | 588 | 411 M | $13.3 B |
| 2026 Q1 | 580 | 363 M | $11.5 B |
| 2025 Q4 | 597 | 330 M | $11.7 B |
| 2025 Q3 | 572 | 316 M | $11.8 B |
| 2025 Q2 | 543 | 302 M | $12.0 B |
| 2025 Q1 | 493 | 265 M | $10.1 B |
| 2024 Q4 | 486 | 244 M | $10.7 B |
| 2024 Q3 | 439 | 227 M | $10.9 B |
| 2024 Q2 | 383 | 220 M | $7.43 B |
| 2024 Q1 | 359 | 216 M | $8.14 B |
| 2023 Q4 | 296 | 201 M | $6.70 B |
| 2023 Q3 | 243 | 174 M | $4.38 B |
| 2023 Q2 | 251 | 163 M | $4.53 B |
| 2023 Q1 | 196 | 150 M | $2.96 B |
| 2022 Q4 | 170 | 126 M | $1.57 B |
| 2022 Q3 | 148 | 133 M | $1.60 B |
| 2022 Q2 | 119 | 115 M | $1.29 B |
| 2022 Q1 | 93 | 97.6 M | $1.56 B |
| 2021 Q4 | 83 | 97.3 M | $2.73 B |